Are Coca-Cola shares the prime beverage bets on the London Stock Exchange?

I could (sort of) buy Coca-Cola shares on the London Stock Exchange, but there might be better British beverage stock options.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Young Asian woman holding a cup of takeaway coffee and folders containing paperwork, on her way into the office

Image source: Getty Images

I’ve been wondering whether Coca-Cola shares are the best beverage stocks on the London Stock Exchange.

No, I haven’t lost my mind. It’s possible to buy shares in Coca-Cola that are directly listed on the LSE. Well, sort of. Coca-Cola HBC AG and Coca-Cola Europacific Partners are UK listed. They’re licensed to bottle and distribute Coca-Cola products on behalf of the US-listed Coca-Cola Company in Europe and Africa to Asia and the Pacific.

The choice dilemma

The Coca-Cola bottler companies aren’t the only beverage stocks listed on the LSE. The likes of Britvic, AG Barr, Nichols, and Fevertree are also there for consideration. So, which of these four drinks makers and the two bottlers do I like the most?

I’m biased towards quality over value, momentum, growth, or any other factor. I measure quality by looking at snapshot ratios for profitability, efficiency, leverage and liquidity.

Britvic had the best return on equity over the last 12 months. Fevertree and A G Barr have the best operating margins. Britvic and Nichols are the best at turning inventory into cash and getting the most from their assets, respectively. Fevertree and Nichols look the least leveraged and better prepared to handle their short-term debts. The Coca-Cola bottlers don’t stand out as being either good or bad across those measures. But they do trade at price-to-earnings (P/E) ratios — 13.8 for Coca-Cola HBC and 14.6 for Coca-Cola Europacific Partners — that are below average for the beverages industry.

Unfortunately, Fevertree doesn’t look cheap at all. It trades at a forward P/E ratio of 52. Nichols is better placed with its P/E of 20. But that’s still above average for beverage stocks. AG Barr is about average on 17 while Britvic has a P/E ratio of 14. So, AG Barr and Britvic look promising, along with the solidly performing Coca-Cola bottlers.

UK beverage stocks

The Coca-Cola Company has tight control of where and how much the Coca-Cola bottlers produce, and how profitable they are. Since they’re not in full control of their destiny, I don’t think I can consider them as my pick of the beverage stock bunch. So, I’m left with Britvic and AG Barr.

Britvic has its own brands. But it also bottles and sells drinks in the UK on behalf of others like Pepsi. AG Barr does some bottling but not as much as Britvic. The sheer volume of Pepsi that’s sold in the UK probably explains why Britvic’s average operating margin of 10.4% is lower than AG Barr’s 15.5%. Britvic appears to be more like the Coca-Cola bottlers than I’d like.

While Britvic has an edge in size and overseas markets over AG Barr (which should reduce its risk), I prefer the latter. I like AG Barr’s focus on smaller markets where it might have an edge. It owns Irn-Bru, the top-selling soft drink in Scotland. And it recently bought an oat milk business (MOMA) with a strong position in a growing market.

All things considered, if I had to pick my prime beverage stock bet on the LSE, that’s the one I’d go for.

James McCombie has no position in any of the shares mentioned. The Motley Fool UK has recommended A.g. Barr P.l.c., Britvic Plc, Fevertree Drinks Plc, Monster Beverage, and Nichols Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »